Contract 36F79725D0219
Asegua Therapeutics Llc · Department Of Veterans Affairs · September 10, 2025
Asegua Therapeutics Llc was awarded a federal contract by Department Of Veterans Affairs on September 10, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 10, 2026. If all options are exercised, the contract could reach $45.10 million.
Contract details
- PIID
- 36F79725D0219
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 10, 2025
- Latest action
- March 10, 2026
Description
2026 SMALL BUSINESS SUBCONTRACTING PLAN
Modification timeline
-
March 10, 2026Mod P00004$0
-
December 1, 2025Mod P00003TEMPORARY PRICE REDUCTION$0
-
November 25, 2025Mod P000022026 PUBLIC LAW PRICING UPDATE$0
-
September 16, 2025Mod P00001TEMPORARY PRICE REDUCTION$0
-
September 10, 2025Base award65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79725D0219?
Contract 36F79725D0219 is a federal contract awarded to Asegua Therapeutics Llc by Department Of Veterans Affairs on September 10, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36F79725D0219?
Asegua Therapeutics Llc won contract 36F79725D0219 from Department Of Veterans Affairs.
How much is contract 36F79725D0219 worth?
Contract 36F79725D0219 has obligated $0 to date but carries a potential ceiling of $45.10 million if fully funded and all options are exercised.